Yritä tehdä uusi haku
6
ORD
Nimi | Ikä | Vuodesta | Otsikko |
---|---|---|---|
Steven G. Gourlay | 62 | 2021 | MD, CEO & Director |
Alan Keith Boyd | 66 | - | Member of Scientific Advisory Board |
Geoffrey Edward Duncan Brooke | 65 | 2017 | Independent Non-Executive Chairman |
Christina Kurre Olsen | - | 2022 | Member of Depression & Cognition Clinical Advisory Board |
Christopher Chen | - | 2022 | Member of Depression & Cognition Clinical Advisory Board |
Jeffrey L. Cummings | 73 | 2015 | Member of Xanamem Clinical Advisory Board |
Jonathan Seckl | - | - | Member of Scientific Advisory Board |
Malcolm John McComas | 68 | 2019 | Independent Non-Executive Director |
Brian R. Walker | - | - | Member of Scientific Advisory Board |
Craig W. Ritchie | - | 2015 | Chairman of Xanamem Clinical Advisory Board |
Colin Louis Masters | 76 | 2015 | Member of Xanamem Clinical Advisory Board |
George Morstyn | 73 | 2017 | Independent Non-Executive Director |
Scott Webster | - | - | Member of Scientific Advisory Board |
John Harrison | - | 2022 | Member of Depression & Cognition Clinical Advisory Board |
Nicki Vasquez | 59 | 2023 | Independent Non-Executive Director |
Dana C. Hilt | 70 | 2022 | Chief Medical Officer & Member of Depression and Cognition Clinical Advisory Board |
Haluatko varmasti estää käyttäjän %USER_NAME%?
Toimiessasi näin sinä ja %USER_NAME% ette voi nähdä toistenne Investing.com-julkaisuja.
Käyttäjän %USER_NAME% lisääminen estoluetteloosi onnistui
Koska olet juuri poistanut eston tämän henkilön kohdalla, sinun täytyy odottaa 48 tuntia ennen estämisen uusimista.
Mielestäni tämä kommentti on:
Kiitos!
Raporttisi on lähetetty moderaattoreidemme tarkastettavaksi